Literature DB >> 12077090

Related IgA1 and IgG producing cells in blood and diseased mucosa in ulcerative colitis.

V C Thoree1, S J C Golby, L Boursier, M Hackett, D K Dunn-Walters, J D Sanderson, J Spencer.   

Abstract

BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory bowel disease in which the colonic mucosa is infiltrated with plasma cells producing IgG autoantibodies. It is not known whether this represents a local mucosal response which has switched to IgG or a peripheral response which may have been initiated by peripheral antigen which homed to the colonic mucosa. The clonal distribution of IgG secreting cells and isotype switched variants in UC is not known. AIMS: To investigate the clonal distribution of mucosal IgG in UC and to search for related IgG and IgA secreting cells in normal and diseased mucosa and blood in UC. To investigate characteristics which may discriminate between the mucosal and peripheral repertoire in the normal mucosa and in UC. PATIENTS: Blood and normal and diseased mucosa from two patients with UC were studied.
METHODS: Immunoglobulin gene analysis and clone specific polymerase chain reaction were used to study the clonal distribution and characteristics of IgG and related IgA in the mucosa and blood of patients with UC.
RESULTS: The IgG response in the mucosa of UC patients included widespread clones of cells that were present in both the diseased mucosa and blood but that were scarce in normal mucosa. Clonally related IgA class switch variants, all IgA1, were detected but also only in the diseased mucosa and blood. This suggests that these clones home preferentially to the diseased mucosa. We showed that J(H)1 usage was characteristic of the peripheral repertoire, and that examples of J(H)1 usage were observed in mucosal IgG in UC.
CONCLUSIONS: Overall, these data are consistent with a model of UC in which a peripheral response is expressed and expanded in the colonic mucosa.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077090      PMCID: PMC1773274          DOI: 10.1136/gut.51.1.44

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

Review 1.  Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity.

Authors:  E C Butcher
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

2.  Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients.

Authors:  S R Targan; C J Landers; L Cobb; R P MacDermott; A Vidrich
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

3.  Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis.

Authors:  X Geng; L Biancone; H H Dai; J J Lin; N Yoshizaki; A Dasgupta; F Pallone; K M Das
Journal:  Gastroenterology       Date:  1998-05       Impact factor: 22.682

4.  Sequence analysis of human IgVH genes indicates that ileal lamina propria plasma cells are derived from Peyer's patches.

Authors:  D K Dunn-Walters; P G Isaacson; J Spencer
Journal:  Eur J Immunol       Date:  1997-02       Impact factor: 5.532

5.  Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction.

Authors:  H P Brezinschek; R I Brezinschek; P E Lipsky
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

6.  Use of the most JH-proximal human Ig H chain V region gene, VH6, in the expressed immune repertoire.

Authors:  W S Varade; E Marin; A M Kittelberger; R A Insel
Journal:  J Immunol       Date:  1993-06-01       Impact factor: 5.422

7.  Hypermutation, diversity and dissemination of human intestinal lamina propria plasma cells.

Authors:  D K Dunn-Walters; L Boursier; J Spencer
Journal:  Eur J Immunol       Date:  1997-11       Impact factor: 5.532

8.  Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel diseases.

Authors:  M Salmi; K Granfors; R MacDermott; S Jalkanen
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

9.  Preferential utilization of the immature JH segment and absence of somatic mutation in the CDR3 junction of the Ig H chain gene in three X-linked severe combined immunodeficiency patients.

Authors:  Y Minegishi; H Okawa; K Sugamura; J Yata
Journal:  Int Immunol       Date:  1994-11       Impact factor: 4.823

10.  Induction and function of vascular adhesion protein-1 at sites of inflammation.

Authors:  M Salmi; K Kalimo; S Jalkanen
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  12 in total

1.  Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells.

Authors:  Michael E Burczynski; Ron L Peterson; Natalie C Twine; Krystyna A Zuberek; Brendan J Brodeur; Lori Casciotti; Vasu Maganti; Padma S Reddy; Andrew Strahs; Fred Immermann; Walter Spinelli; Ulrich Schwertschlag; Anna M Slager; Monette M Cotreau; Andrew J Dorner
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

2.  [Linear IgA disease with ocular involvement associated with ulcerative colitis].

Authors:  A Klein; S M Wenzel; E M Messmer; M Landthaler; T Vogt
Journal:  Hautarzt       Date:  2010-01       Impact factor: 0.751

3.  IGHV1, IGHV5 and IGHV7 subgroup genes in the rhesus macaque.

Authors:  Jon M Bible; Wendy Howard; Helena Robbins; Deborah K Dunn-Walters
Journal:  Immunogenetics       Date:  2003-02-21       Impact factor: 2.846

4.  Molecular characterization of the cervical and systemic B-cell repertoire: Unique, yet overlapping, immune compartments of an HIV-1 resistant individual.

Authors:  Ryan G Gaudet; Felix Breden; Frank Plummer; Jody D Berry
Journal:  MAbs       Date:  2011-03-01       Impact factor: 5.857

5.  NK cell spatial dynamics and IgA responses in gut-associated lymphoid tissues during SIV infections.

Authors:  Philippe Rascle; Cyril Planchais; Béatrice Jacquelin; Marie Lazzerini; Vanessa Contreras; Caroline Passaes; Asier Saez-Cirion; Hugo Mouquet; Nicolas Huot; Michaela Müller-Trutwin
Journal:  Commun Biol       Date:  2022-07-07

6.  Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.

Authors:  E Furrie; S Macfarlane; J H Cummings; G T Macfarlane
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

7.  Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases.

Authors:  T H J Florin; N Pandeya; G L Radford-Smith
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

8.  Characterization of cells of the B lineage in the human adult greater omentum.

Authors:  Laurent Boursier; Stephen Attard Montalto; Shanti Raju; Giuseppe Culora; Jo Spencer
Journal:  Immunology       Date:  2006-09       Impact factor: 7.397

9.  Alteration of DSS-mediated immune cell redistribution in murine colitis by oral colostral immunoglobulin.

Authors:  Peggy Bodammer; Elisabeth Zirzow; Sebastian Klammt; Claudia Maletzki; Claus Kerkhoff
Journal:  BMC Immunol       Date:  2013-02-20       Impact factor: 3.615

10.  Testing stem cell therapy in a rat model of inflammatory bowel disease: role of bone marrow stem cells and stem cell factor in mucosal regeneration.

Authors:  Bo Qu; Guo-Rong Xin; Li-Xia Zhao; Hui Xing; Li-Ying Lian; Hai-Yan Jiang; Jia-Zhao Tong; Bei-Bei Wang; Shi-Zhu Jin
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.